Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes:A Clinical Update of Safety and Efficacy

ABSTRACT: INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly being used for the treatment of type 2 diabetes mellitus, but consideration of benefits and potential adverse events is required. This review examines the state of glycemic control, weight loss, blood pres...

Descripción completa

Detalles Bibliográficos
Autor principal: Drab, Scott R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101635/
https://www.ncbi.nlm.nih.gov/pubmed/26694823
http://dx.doi.org/10.2174/1573399812666151223093841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101635/
https://www.ncbi.nlm.nih.gov/pubmed/26694823
http://dx.doi.org/10.2174/1573399812666151223093841

Ejemplares similares